We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Nurix Therapeutics Inc
6 own
4 watching
Current Price
$21.37
$1.31
(6.53%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,616.09M
52-Week High
29.56000
52-Week Low
7.65000
Average Volume
1.02M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,616.09M52-Week High29.5600052-Week Low7.65000Average Volume1.02MDividend Yield--P/E Ratio--What does the Nurix Therapeutics Inc do?
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton s tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally available Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It also develops NX-0255, a CBL-B inhibitor for ex vivo use to enhance adoptive T-cell therapy; and DeTIL-0255 that is in the Phase 1 clinical trial for the treatment of gynecologic cancers, including ovarian, endometrial, and cervical cancer. The company has a strategic collaboration agreement with Gilead Sciences, Inc. for cancer and other challenging diseases patients; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. The company was incorporated in 2009 and is headquartered in San Francisco, California.
Read More
How much money does Nurix Therapeutics Inc make?
News & Events about Nurix Therapeutics Inc.
TipRanks Financial Blog
1 year ago
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nurix Therapeutics (NRIX Research Report), MoonL... Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nurix Therapeutics (NRIX Research Report), MoonLake ...
Zolmax
1 year ago
Nurix Therapeutics, Inc. (NASDAQ:NRIX Get Rating) has been assigned a consensus rating of Moderate Buy from the twelve brokerages that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and ten have assigned a buy ...
Benzinga
1 year ago
Latest Ratings for NRIX
DateFirmActionFromTo Feb 2022Wells FargoInitiates Coverage OnEqual-Weight Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Oct 2021SVB LeerinkMaintainsOutperform
View More Analyst Ratings for NRIX
View the Latest Analyst Ratings
read more...
Benzinga
1 year ago
Latest Ratings for NRIX
DateFirmActionFromTo Feb 2022Wells FargoInitiates Coverage OnEqual-Weight Dec 2021HC Wainwright & Co.Initiates Coverage OnBuy Oct 2021SVB LeerinkMaintainsOutperform
View More Analyst Ratings for NRIX
View the Latest Analyst Ratings
read more...
Globe Newswire
1 year ago
-- IRAK4 Program Represents the First of Up to Five Degrader Programs Within the 2019 Discovery Collaboration Agreement -- -- Nurix to Receive a $20 Million Option Fee -- FOSTER CITY, Calif. and SAN FRANCISCO, March 20, 2023 (GLOBE NEWSWIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) and Nurix ...
Frequently Asked Questions
Frequently Asked Questions
What is Nurix Therapeutics Inc share price today?
Can Indians buy Nurix Therapeutics Inc shares?
How can I buy Nurix Therapeutics Inc shares from India?
Can Fractional shares of Nurix Therapeutics Inc be purchased?
What are the documents required to start investing in Nurix Therapeutics Inc stocks?
What is today’s traded volume of Nurix Therapeutics Inc?
What is today’s market capitalisation of Nurix Therapeutics Inc?
What is the 52-Week High and Low Range of Nurix Therapeutics Inc?
What percentage is Nurix Therapeutics Inc down from its 52-Week High?
What percentage is Nurix Therapeutics Inc up from its 52-Week Low?
Current Price
$21.37
$1.31
(6.53%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.